org placeholder image

Sarah Denny

Director at Scribe Therapeutics

  • LinkedIn

Email Email: s****@scribetx.com

phone noPhone Number: (***)-***-****

Working at the crossroads of biophysics and genetics.

Read More

map
SCRIBE THERAPEUTICS

SCRIBE THERAPEUTICS

  • description Description
    Scribe is enabling the creation of genetic medicines through its CRISPR by DesignTM approach to genetic modification.
  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Scribe Therapeutics Org Chart and Mapping

Benjamin Oakes

Chief Executive Officer

Employees

Yuexuan Li

Scientist I, Drug Product Development

Kirsten Reimer

Senior Bioinformatics Scientist

Michelle Eggers

Senior Director, Preclinical Study Management

Shyam Bale

Senior Scientist II, Discovery

Kai-Yuan Chen

Director of Data Science and Tech Platform

Santhosh Karanth

Investigator/Senior Scientist

Frequently Asked Questions Regarding Sarah Denny

Answer: Sarah Denny works for Scribe Therapeutics as Director

Answer: Sarah Denny’s role in Scribe Therapeutics is Director

Answer: Sarah Denny's email address is s***@gmail.com

Answer: Sarah Denny's business email address is s****@scribetx.com

Answer: Sarah Denny’s direct phone number is (***)-***-****

Answer: Sarah Denny works in the industry of: Biotechnology

Answer: Sarah Denny is the current Director at Scribe Therapeutics.... Read More

Answer: Sarah Denny works Scribe Therapeutics located at 1150 Marina VLG Pkwy, Alameda, California, 94501, United States

Answer: Scribe Therapeutics's Director is Sarah Denny

Answer: Sarah Denny contact details:

  • Phone number  :  (***)-***-****
  • Email  :  s****@scribetx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access